1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Radiopharmaceutical Theranostics Market – by Product Type

1.3.2        Asia Pacific Radiopharmaceutical Theranostics Market – by Radioisotope

1.3.3        Asia Pacific Radiopharmaceutical Theranostics Market – by Source

1.3.4        Asia Pacific Radiopharmaceutical Theranostics Market – by Application

1.3.5        Asia Pacific Radiopharmaceutical Theranostics Market – by Indication

1.3.6        Asia Pacific Radiopharmaceutical Theranostics Market – by End User

1.3.7        Asia Pacific Radiopharmaceutical Theranostics Market – by Country

2.           Radiopharmaceutical Theranostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Radiopharmaceutical Theranostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific PEST Analysis

4.3         Expert’s Opinion

5.           Asia Pacific Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidence of Cancer

5.1.2        Rising Application in Treatment of Cardiovascular Disorders

5.2         Market Restraints

5.2.1        Regulatory Challenges for Approval of Radiopharmaceutical Theranostics

5.3         Market Opportunities

5.3.1        Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies

5.4         Future Trends

5.4.1        Radiopharmaceutical Theranostics in Nuclear Medicine

5.5         Impact Analysis

6.           Radiopharmaceutical Theranostics Market – Asia Pacific Analysis

6.1         Asia Pacific Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7.           Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

7.2.1        Positron Emission Tomography (PET) Tracers

7.2.1.1          Overview

7.2.1.2          Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.2        Beta Emitters

7.2.2.1          Overview

7.2.2.2          Beta Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.3        Alpha Emitters

7.2.3.1          Overview

7.2.3.2          Alpha Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1         Overview

8.2         Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)

8.2.1        Technetium-99

8.2.1.1          Overview

8.2.1.2          Technetium-99: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.2        Gallium-68

8.2.2.1          Overview

8.2.2.2          Gallium-68: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.3        Iodine-131

8.2.3.1          Overview

8.2.3.2          Iodine-131: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4        Iodine-123

8.2.4.1          Overview

8.2.4.2          Iodine-123: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.5        Fluorine-18 (18F)

8.2.5.1          Overview

8.2.5.2          Fluorine-18 (18F): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.6        Yttrium 90 (Y-90)

8.2.6.1          Overview

8.2.6.2          Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.7        Lutetium (LU) 177

8.2.7.1          Overview

8.2.7.2          Lutetium (LU) 177: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.8        Copper (CU) 67

8.2.8.1          Overview

8.2.8.2          Copper (CU) 67: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.9        Copper (CU) 64

8.2.9.1          Overview

8.2.9.2          Copper (CU) 64: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.10     Others

8.2.10.1       Overview

8.2.10.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Source

9.1         Overview

9.2         Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)

9.2.1        Nuclear Reactors

9.2.1.1          Overview

9.2.1.2          Nuclear Reactors: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.2        Cyclotrons

9.2.2.1          Overview

9.2.2.2          Cyclotrons: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Application

10.1      Overview

10.2      Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)

10.2.1     Targeted Therapeutic (Rx)

10.2.1.1       Overview

10.2.1.2       Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.2     Companion Diagnostic (CDx)

10.2.2.1       Overview

10.2.2.2       Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Indication

11.1      Overview

11.2      Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)

11.2.1     Oncology

11.2.1.1       Overview

11.2.1.2       Oncology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.2     Neurology

11.2.2.1       Overview

11.2.2.2       Neurology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.3     Cardiology

11.2.3.1       Overview

11.2.3.2       Cardiology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.4     Others

11.2.4.1       Overview

11.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.        Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by End User

12.1      Overview

12.2      Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)

12.2.1     Hospitals

12.2.1.1       Overview

12.2.1.2       Hospitals: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.2     Diagnostic Imaging Centers

12.2.2.1       Overview

12.2.2.2       Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3     Academic & Research Institutes

12.2.3.1       Overview

12.2.3.2       Academic & Research Institutes: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.4     Others

12.2.4.1       Overview

12.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.        Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Country Analysis

13.1      Asia Pacific: Radiopharmaceutical Theranostics Market

13.1.1     Overview

13.1.2     Asia Pacific: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

13.1.2.1       China: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1       Overview

13.1.2.1.2       China: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3       China Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.1.4       China Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.1.5       China Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.1.6       China Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.1.7       China Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.1.8       China Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.2       Japan: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1       Overview

13.1.2.2.2       Japan: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3       Japan Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.2.4       Japan Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.2.5       Japan Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.2.6       Japan Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.2.7       Japan Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.2.8       Japan Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.3       India: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1       Overview

13.1.2.3.2       India: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3       India Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.3.4       India Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.3.5       India Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.3.6       India Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.3.7       India Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.3.8       India Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.4       South Korea: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.1       Overview

13.1.2.4.2       South Korea: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.3       South Korea Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.4.4       South Korea Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.4.5       South Korea Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.4.6       South Korea Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.4.7       South Korea Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.4.8       South Korea Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.5       Australia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.1       Overview

13.1.2.5.2       Australia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.3       Australia Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.5.4       Australia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.5.5       Australia Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.5.6       Australia Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.5.7       Australia Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.5.8       Australia Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.6       Rest of Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.1       Overview

13.1.2.6.2       Rest of Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.3       Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.6.4       Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.6.5       Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.6.6       Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.6.7       Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.6.8       Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

14.        Radiopharmaceutical Theranostics Market – Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Radiopharmaceutical Theranostics Market

14.3      Inorganic Growth Strategies

14.3.1     Overview

14.4      Organic Growth Strategies

14.4.1     Overview

15.        Company Profiles

15.1      Bayer AG

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      GE HealthCare Technologies Inc

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Curium

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      Telix Pharmaceuticals Ltd.

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      Cardinal Health Inc

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             China Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 3.             China Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Japan Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Japan Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Japan Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Japan Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Japan Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          India Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          India Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 15.          India Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 16.          India Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17.          India Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 18.          India Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          South Korea Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          South Korea Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 21.          South Korea Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 22.          South Korea Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 23.          South Korea Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 24.          South Korea Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Australia Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Australia Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Australia Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Australia Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Australia Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Australia Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37.          Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 38.          Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 39.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Asia Pacific Radiopharmaceutical Theranostics Market Segmentation

Figure 2.           Asia Pacific Radiopharmaceutical Theranostics Market, by Country

Figure 3.           Asia Pacific Radiopharmaceutical Theranostics Market Overview

Figure 4.           Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market

Figure 5.           India Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Asia Pacific Experts’ Opinion

Figure 8.           Asia Pacific Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        Asia Pacific Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11.        Positron Emission Tomography (PET) Tracers: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Beta Emitters: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Alpha Emitters: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)

Figure 15.        Technetium-99: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Gallium-68: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Iodine-131: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Iodine-123: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Fluorine-18 (18F): Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Yttrium 90 (Y-90): Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Lutetium (LU) 177: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Copper (CU) 67: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Copper (CU) 64: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Others: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Asia Pacific Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)

Figure 26.        Nuclear Reactors: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Cyclotrons: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Asia Pacific Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)

Figure 29.        Targeted Therapeutics (Rx): Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Companion Diagnostics (CDx): Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Asia Pacific Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)

Figure 32.        Oncology: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Neurology: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Cardiology: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Asia Pacific Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)

Figure 37.        Hospitals: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Diagnostic Imaging Centers: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Academic & Research Institutes: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Others: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Asia Pacific: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 42.        China: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Japan: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        India: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        South Korea: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Australia: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47.        Rest of Asia Pacific: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48.        Growth Strategies in the Radiopharmaceutical Theranostics Market